newsfilter
← Latest News
PR Newswire·

INVO Bioscience Announces Closing of $4.5 Million Public Offering

SARASOTA, Fla., Aug. 8, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment